Company
NRG Therapeutics
Next-generation disease-modifying medicines for ALS and Parkinson’s
- Business model
- B2B
- Legal name
- NRG Therapeutics Ltd
Claim, correct or request removal
Record updated 28 September 2026
About
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders
Products
- Web
- NRG5051
Loading relationship preview